BzATP triethylammonium salt Size:Contact [email protected] for quotation 12 hours) shows near complete

12 hours) shows near complete AR degradation (>98%) in prostate cancer cells

IRAK4-IN-1 is a novel potent and selective IRAK4 inhibitor

31)32)12-15-24(23)34-25)27(30)20-10-13-22(14-11-20)33-18-8-17-28-16-7-5-2

COC1=CC(=CC=C1[N+]1=NC(=NN1C1C=CC(=CC=1)[N+]([O-])=O)C1=CC=C(C=C1S([O-])(=O)=O)S([O-])(=O)=O)[N+]([O-])=O

35(2):284-95

BzATP triethylammonium salt Size:Contact [email protected] for quotation 12 hours) shows near completeBzATP triethylammonium salt acts as a P2X receptor agonist with pEC50s of 8. 74, 5. 26, 7. 10, 7. 50, 6. 19, 6. 31, 5. 33 for P2X1, P2X2, P2X3, P2X2 3, P2X4 and P2X7, respectively. BzATP triethylammonium salt is potent at P2X7 receptors with EC50s of 3. 6 M and 285 M for rat P2X7 and mouse P2X7, respectively. Product information CAS Number: 112898 15 4 Molecular Weight: 816. 58 Formula: C30H39N6O15P3 Chemical Name: ({[({[(2R,3S,4R,5R) 5 (6 amino 9H